|
⚲
|
| Keyboard |
| Gopinathan Suma
✚
|
|
|---|---|
| CIK # | 0002071581 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002071581] | |
| 4 | [0002071581] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lexicon Pharmaceuticals Inc | |
| Gopinathan Suma |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2026-02-28 | Option exercise | 65,640 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2026-02-28 | Option exercise | 14,000 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2026-02-28 | Option exercise | 20,310 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-28 | Option exercise | 65,640 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-28 | Tax withheld | 24,338 | $1.47 | 35,777 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-28 | Option exercise | 20,310 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-28 | Option exercise | 14,000 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2026-02-12 | Grant | 238,450 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2026-02-12 | Grant | 357,680 | $0.00 |